Patents by Inventor Paul Blaney

Paul Blaney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CRYSTALLINE FORMS OF HYDROXYNORKETAMINE
    Publication number: 20220306569
    Abstract: The present invention provides novel, stable, processable and pharmaceutically acceptable salt forms of 2R,6R-hydrox-ynorketamineor 2S,6S-hydroxynorketamine with high aqueous solubility.
    Type: Application
    Filed: May 27, 2022
    Publication date: September 29, 2022
    Applicant: Small Pharma Ltd
    Inventors: David PEARSON, Lorraine SHARP, Alan ARMSTRONG, Richard MYERSON, Jonathan HULL, Paul BLANEY, Peter RANDS, Marie LAYZELL, Zelah JOEL
  • Crystalline forms of hydroxynorketamine
    Patent number: 11377416
    Abstract: The present invention provides novel, stable, processable and pharmaceutically acceptable salt forms of 2R,6R-hydroxynorketamine or 2S,6S-hydroxynorketamine with high aqueous solubility.
    Type: Grant
    Filed: July 31, 2018
    Date of Patent: July 5, 2022
    Assignee: SMALL PHARMA LTD.
    Inventors: David Pearson, Lorraine Sharp, Alan Armstrong, Richard Myerson, Jonathan Hull, Paul Blaney, Peter Rands, Marie Layzell, Zelah Joel
  • CRYSTALLINE FORMS OF HYDROXYNORKETAMINE
    Publication number: 20200157040
    Abstract: The present invention provides novel, stable, processable and pharmaceutically acceptable salt forms of 2R,6R-hydroxynorketamine or 2S,6S-hydroxynorketamine with high aqueous solubility.
    Type: Application
    Filed: July 31, 2018
    Publication date: May 21, 2020
    Applicant: SMALL PHARMA LTD
    Inventors: David Pearson, Lorraine Sharp, Alan Armstrong, Richard Myerson, Jonathan Hull, Paul Blaney, Peter Rands, Marie Layzell, Zelah Joel
  • Azadecalin glucocorticoid receptor modulators
    Patent number: 8324203
    Abstract: The present invention provides a novel class of azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Grant
    Filed: January 21, 2010
    Date of Patent: December 4, 2012
    Assignee: Corcept Therapeutics, Inc.
    Inventors: Robin D. Clark, Nicholas C. Ray, Paul Blaney, Christopher Hurley, Hazel Hunt, David Clark, Karen Williams
  • Indolizine Acetic Acid Derivatives as CRTH2 Antagonists
    Publication number: 20100137300
    Abstract: The specific compounds of this list: {7-cyano-2-methyl-1-[4-(morpholine-4-sutfonyl)benzyl]indolizin-3-yl}acetic acid, {1-(3-chloro-4-ethanesulfonylbenzyl)-7-cyano-2-methylindolizin-3-yl}acetic acid, {1-[3-chloro4-(morpholine-4-sulfonyl)benzyl]-7-cyano-2-methylindolizin-3-yl}acetic acid, {1-(3-chloro-4-ethanesulfonylphenylsulfanyl)-7-cyano-2-methylindolizin-3-yl}acetic acid, {1-[3-chloro-4-(morpholine-4-sutfonyl)phenylsutfanyl]-7-cyano-2-methylindolizin-3-yl}acetic acid, {7-cyano-1-(6-fluoroquinolin-2-ylmethyl)-2-methylindolizin-3-yl}acetic acid are ligands of the CRTH2 receptor and are useful in the treatment of respiratory diseases.
    Type: Application
    Filed: March 21, 2007
    Publication date: June 3, 2010
    Inventors: George Hynd, Nicholas Charles Ray, Harry Finch, John Gary Montana, Michael Colin Cramp, Trevor Keith Harrison, Rosa Arienzo, Paul Blaney, Yann Griffon, David Middlemiss
  • AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS
    Publication number: 20100120759
    Abstract: The present invention provides a novel class of azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Application
    Filed: January 21, 2010
    Publication date: May 13, 2010
    Applicant: Corcept Therapeutics, Inc.
    Inventors: Robin D. CLARK, Nicholas C. RAY, Paul BLANEY, Christopher HURLEY, Hazel HUNT, David CLARK, Karen WILLIAMS
  • Azadecalin Glucocorticoid receptor modulators
    Patent number: 7678813
    Abstract: The present invention provides a novel class of azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Grant
    Filed: January 10, 2005
    Date of Patent: March 16, 2010
    Assignee: Corcept Therapeutics, Inc.
    Inventors: Robin D. Clark, Nicholas C. Ray, Paul Blaney, Christopher Hurley, Hazel Hunt, David Clark, Karen Williams
  • Indolizine Derivatives as Ligands of the Crth2 Receptor
    Publication number: 20080306109
    Abstract: Compounds of formula (I) are CRTH2 antagonists, useful in the treatment of, for example, asthma, chronic obstructive pulmonary disease, rhinitis, allergic airway syndrome, and allergic rhinobronchitis. Formula (I) wherein R1, R2.
    Type: Application
    Filed: September 14, 2006
    Publication date: December 11, 2008
    Inventors: George Hynd, Nicholas Charles Ray, Harry Finch, John Gary Montana, Michael Colin Cramp, Trevor Keith Harrison, Rosa Arienzo, Paul Blaney, Yann Griffon, David Middlemiss
  • Fused Ring Azadecalin Glucocorticoid Receptor Modulators
    Publication number: 20070281928
    Abstract: The present invention provides a novel class of fused ring azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Application
    Filed: March 9, 2005
    Publication date: December 6, 2007
    Inventors: Robin Clark, Nicholas Ray, Paul Blaney, Christopher Hurley, Karen Williams
  • Azadecalin Glucocorticoid Receptor Modulators
    Publication number: 20070203179
    Abstract: The present invention provides a novel class of azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.
    Type: Application
    Filed: January 10, 2005
    Publication date: August 30, 2007
    Applicant: Corcept Therapeutics, Inc.
    Inventors: Robin Clark, Nicholas Ray, Paul Blaney, Christopher Hurley, Hazel Hunt, David Clark, Karen Williams
  • Medicament
    Publication number: 20050159484
    Abstract: The present invention relates to 3?,28-diacetoxy-18-oxo-19,20,21,29,30-pentanorlupan-22-oic acid methanol solvate, its use in medicine and processes for its preparation.
    Type: Application
    Filed: May 14, 2004
    Publication date: July 21, 2005
    Inventors: Peter Fischer, Jan Sarek, Paul Blaney, Piers Collier, John Ferguson, Jonathan Hull